Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara Cassino

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|April 3, 2019
Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureusJun Taek Oh, Cara Cassino, Raymond Schuch
Frontiers in Microbiology|March 21, 2022
Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic ResistanceRaymond Schuch, Cara Cassino, Xavier Vila-Farres
Diagnostic Microbiology and Infectious Disease|August 31, 2019
In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017Maria Traczewski, Jun Oh, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2019
Exebacase Demonstrates <i>In Vitro</i> Synergy with a Broad Range of Antibiotics against both Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureusAubrey Watson, Karen Sauve, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Exebacase Is Active <i>In Vitro</i> in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung InfectionSteven M Swift, Karen Sauve, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2021
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing"Jun T Oh, Jane E Ambler, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Development of a Broth Microdilution Method for Exebacase Susceptibility TestingJun T Oh, Jane E Ambler, Cara Cassino, et al.
Pharmacotherapy|November 25, 2005
Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary diseaseHenry Covelli, Sudipta Bhattacharya, Cara Cassino, et al.
BMC Research Notes|September 12, 2023
In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wiresMelissa J Karau, Jay Mandrekar, Dario Lehoux, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective EndocarditisAubrey Watson, Jun Taek Oh, Karen Sauve, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|April 3, 2019
Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureusJun Taek Oh, Cara Cassino, Raymond Schuch
Frontiers in Microbiology|March 21, 2022
Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic ResistanceRaymond Schuch, Cara Cassino, Xavier Vila-Farres
Diagnostic Microbiology and Infectious Disease|August 31, 2019
In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017Maria Traczewski, Jun Oh, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2019
Exebacase Demonstrates <i>In Vitro</i> Synergy with a Broad Range of Antibiotics against both Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureusAubrey Watson, Karen Sauve, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Exebacase Is Active <i>In Vitro</i> in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung InfectionSteven M Swift, Karen Sauve, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2021
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing"Jun T Oh, Jane E Ambler, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Development of a Broth Microdilution Method for Exebacase Susceptibility TestingJun T Oh, Jane E Ambler, Cara Cassino, et al.
Pharmacotherapy|November 25, 2005
Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary diseaseHenry Covelli, Sudipta Bhattacharya, Cara Cassino, et al.
BMC Research Notes|September 12, 2023
In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wiresMelissa J Karau, Jay Mandrekar, Dario Lehoux, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective EndocarditisAubrey Watson, Jun Taek Oh, Karen Sauve, et al.
Pageof 3